Works matching AU Takeuchi, Kengo


Results: 164
    1

    Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00170-7
    By:
    • Yoshizawa, Takahiro;
    • Uchibori, Ken;
    • Araki, Mitsugu;
    • Matsumoto, Shigeyuki;
    • Ma, Biao;
    • Kanada, Ryo;
    • Seto, Yosuke;
    • Oh-hara, Tomoko;
    • Koike, Sumie;
    • Ariyasu, Ryo;
    • Kitazono, Satoru;
    • Ninomiya, Hironori;
    • Takeuchi, Kengo;
    • Yanagitani, Noriko;
    • Takagi, Satoshi;
    • Kishi, Kazuma;
    • Fujita, Naoya;
    • Okuno, Yasushi;
    • Nishio, Makoto;
    • Katayama, Ryohei
    Publication type:
    Article
    2
    3
    4
    5

    Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40026-7
    By:
    • Shirouchi, Yuko;
    • Nishimura, Noriko;
    • Mishima, Yuko;
    • Ishihara, Yuko;
    • Asai, Hiroaki;
    • Tamba, Mikako;
    • Hirano, Mitsuhito;
    • Hirano, Kei;
    • Teramoto, Yukako;
    • Yoshida, Kikuaki;
    • Takeuchi, Kengo;
    • Terauchi, Takashi;
    • Maruyama, Dai
    Publication type:
    Article
    6

    Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40026-7
    By:
    • Shirouchi, Yuko;
    • Nishimura, Noriko;
    • Mishima, Yuko;
    • Ishihara, Yuko;
    • Asai, Hiroaki;
    • Tamba, Mikako;
    • Hirano, Mitsuhito;
    • Hirano, Kei;
    • Teramoto, Yukako;
    • Yoshida, Kikuaki;
    • Takeuchi, Kengo;
    • Terauchi, Takashi;
    • Maruyama, Dai
    Publication type:
    Article
    7
    8

    Novel THBS1::IGF1R fusion in myopericytic tumour.

    Published in:
    Histopathology, 2024, v. 85, n. 1, p. 197, doi. 10.1111/his.15186
    By:
    • Kato, Kenichiro;
    • Yamashita, Kyoko;
    • Dobashi, Akito;
    • Togashi, Yuki;
    • Baba, Satoko;
    • Ae, Keisuke;
    • Matsumoto, Seiichi;
    • Takeuchi, Kengo
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Report of Four Cases with High-Grade Surface Osteosarcoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2006, v. 36, n. 3, p. 180, doi. 10.1093/jjco/hyi243
    By:
    • Hoshi, Manabu;
    • Matsumoto, Seiichi;
    • Manabe, Jun;
    • Tanizawa, Taisuke;
    • Shigemitsu, Toshio;
    • Takeuchi, Kengo;
    • Kawaguchi, Noriyoshi
    Publication type:
    Article
    15
    16
    17
    18

    APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.

    Published in:
    British Journal of Cancer, 2024, v. 130, n. 1, p. 151, doi. 10.1038/s41416-023-02484-8
    By:
    • Chen, Mingjue;
    • Mashima, Tetsuo;
    • Oishi, Taichi;
    • Muramatsu, Yukiko;
    • Seto, Yosuke;
    • Takamatsu, Manabu;
    • Kawata, Naomi;
    • Morino, Shun;
    • Nakamura, Ayane;
    • Inaba, Saori;
    • Yuan, Xunmei;
    • Maruyama, Kohei;
    • Suzuki, Mai;
    • Sato, Ayana;
    • Yoshida, Haruka;
    • Jang, Myung-Kyu;
    • Mizutani, Anna;
    • Takeuchi, Kengo;
    • Yamaguchi, Kensei;
    • Shirai, Fumiyuki
    Publication type:
    Article
    19
    20

    Evaluation of the RAS signaling network in response to MEK inhibition using organoids derived from a familial adenomatous polyposis patient.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74530-x
    By:
    • Osumi, Hiroki;
    • Muroi, Atsushi;
    • Sakahara, Mizuho;
    • Kawachi, Hiroshi;
    • Okamoto, Takuya;
    • Natsume, Yasuko;
    • Yamanaka, Hitomi;
    • Takano, Hiroshi;
    • Kusama, Daisuke;
    • Shinozaki, Eiji;
    • Ooki, Akira;
    • Yamaguchi, Kensei;
    • Ueno, Masashi;
    • Takeuchi, Kengo;
    • Noda, Tetsuo;
    • Nagayama, Satoshi;
    • Koshikawa, Naohiko;
    • Yao, Ryoji
    Publication type:
    Article
    21
    22
    23

    Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 9, p. 2141, doi. 10.1080/10428194.2021.1901091
    By:
    • Uryu, Hideki;
    • Mishima, Yuko;
    • Tsuyama, Naoko;
    • Yokoyama, Masahiro;
    • Nishimura, Noriko;
    • Fukuta, Takanori;
    • Shirouchi, Yuko;
    • Okabe, Takashi;
    • Inoue, Norihito;
    • Takeuchi, Kengo;
    • Terui, Yasuhito
    Publication type:
    Article
    24
    25
    26
    27

    Human leukocyte antigen-DR expression on flow cytometry and tumor-associated macrophages in diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy: retrospective cohort study.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 12, p. 2721, doi. 10.3109/10428194.2014.893311
    By:
    • Yamamoto, Wataru;
    • Nakamura, Naoya;
    • Tomita, Naoto;
    • Takeuchi, Kengo;
    • Ishii, Yoshimi;
    • Takahashi, Hiroyuki;
    • Watanabe, Reina;
    • Takasaki, Hirotaka;
    • Motomura, Shigeki;
    • Kobayashi, Shoichi;
    • Yokose, Tomoyuki;
    • Ishigatsubo, Yoshiaki;
    • Sakai, Rika
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Availability of genome-matched therapy based on clinical practice.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 964, doi. 10.1007/s10147-024-02533-z
    By:
    • Hayashi, Naomi;
    • Mori, Seiichi;
    • Ohmoto, Akihiro;
    • Fukada, Ippei;
    • Yamazaki, Masumi;
    • Hosonaga, Mari;
    • Wang, Xiaofei;
    • Ueki, Arisa;
    • Kiyotani, Kazuma;
    • Tonooka, Akiko;
    • Takeuchi, Kengo;
    • Takahashi, Shunji
    Publication type:
    Article
    38
    39
    40
    41
    42

    Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 10, p. 1241, doi. 10.1002/ajh.26292
    By:
    • Nishimura, Yoshito;
    • Fajgenbaum, David C.;
    • Pierson, Sheila K.;
    • Iwaki, Noriko;
    • Nishikori, Asami;
    • Kawano, Mitsuhiro;
    • Nakamura, Naoya;
    • Izutsu, Koji;
    • Takeuchi, Kengo;
    • Nishimura, Midori Filiz;
    • Maeda, Yoshinobu;
    • Otsuka, Fumio;
    • Yoshizaki, Kazuyuki;
    • Oksenhendler, Eric;
    • van Rhee, Frits;
    • Sato, Yasuharu
    Publication type:
    Article
    43

    Frequent inactivation of A20 in B-cell lymphomas.

    Published in:
    Nature, 2009, v. 459, n. 7247, p. 712, doi. 10.1038/nature07969
    By:
    • Kato, Motohiro;
    • Sanada, Masashi;
    • Kato, Itaru;
    • Sato, Yasuharu;
    • Takita, Junko;
    • Takeuchi, Kengo;
    • Niwa, Akira;
    • Chen, Yuyan;
    • Nakazaki, Kumi;
    • Nomoto, Junko;
    • Asakura, Yoshitaka;
    • Muto, Satsuki;
    • Tamura, Azusa;
    • Iio, Mitsuru;
    • Akatsuka, Yoshiki;
    • Hayashi, Yasuhide;
    • Mori, Hiraku;
    • Igarashi, Takashi;
    • Kurokawa, Mineo;
    • Chiba, Shigeru
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50